Abstract
Adenovirus research often requires purified high-titer virus stocks and accurate virus titers for use in experiments. Accurate titers are important for quantitative, interpretable, and reproducible results. This is especially true when there are comparisons of different mutant viruses following infection. This chapter details the large-scale preparation of adenovirus (either replication-competent or replication-defective) in spinner cultures (e.g., KB, HeLa, or 293 cells). Protocols for harvesting cells and isolation of adenovirus by CsCl banding are presented. Methods for titering adenovirus by plaque assay are presented along with a discussion of how plaque assays can be used to determine the kinetics of cell killing and cytolysis by adenoviruses.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Pinteric, L. and Taylor, J. (1962) The lowered drop method for the preparation of specimens of partially purified virus lysates for quantitative electron micrographic analysis. Virology 18, 359–371.
Mittereder, N., March, K. L., and Trapnell, B. C. (1996) Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy. J. Virol. 70, 7498–7509.
Green, M. and Pina, M. (1963) Biochemical studies on adenovirus multiplication. IV. Isolation, purification, and chemical analysis of adenovirus. Virology 20, 199–207.
Green, M. and Wold, W. S.M. (1979) Human adenoviruses: growth, purification, and transfection assay. Methods Enzymol. 58, 425–435.
Hashimoto, S., Sakakibara, N., Kumai, H., et al. (1991) Fastidious human adenovirus type 40 can propagate efficiently and produce plaques on a human cell line, A549, derived from lung carcinoma. J. Virol. 65, 2429–2435.
Green, M., Pina, M., and Kimes, R. C. (1967) Biochemical studies on adenovirus multiplication. XII. Plaquing efficiencies of purified human adenoviruses. Discussion and preliminary reports. Virology 31, 562–565.
Tollefson, A. E., Scaria, A., Herminston, T. W., Ryerse, J. S., Wold, L. J., and Wold, W. S. M. (1996) The adenovirus death protein (E3-11.6K) is required at very late stages of infection for efficient cell lysis and release of adenovirus from infected cells. J. Virol. 70, 2296–2308.
Tollefson, A. E., Ryerse, J. S., Scaria, A, Hermiston, T. W., and Wold, W. S. M. (1996) The E3-11.6kDa adenovirus death protein (ADP) is required for efficient cell death: characterization of cells infected with adp mutants. Virology 220, 152–162.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Humana Press Inc.
About this protocol
Cite this protocol
Tollefson, A.E., Kuppuswamy, M., Shashkova, E.V., Doronin, K., Wold, W.S.M. (2007). Preparation and Titration of CsCl-Banded Adenovirus Stocks. In: Wold, W.S.M., Tollefson, A.E. (eds) Adenovirus Methods and Protocols. Methods in Molecular Medicine, vol 130. Humana Press. https://doi.org/10.1385/1-59745-166-5:223
Download citation
DOI: https://doi.org/10.1385/1-59745-166-5:223
Publisher Name: Humana Press
Print ISBN: 978-1-58829-598-9
Online ISBN: 978-1-59745-166-6
eBook Packages: Springer Protocols